Mkts

Xenetic Biosciences, Inc.

NASDAQ: XBIO
$1.82+0.10 (+5.81%)
As of Oct 26, 2:08 PM ET

Key statistics

Day range
1.581.85
52-week range
1.724.94
Today
Open1.71
Previous close1.82
Volume—
Valuation
Market cap4.47M
P/E ratio—
EPS (TTM)-1.20
Income & risk
Dividend / yield—
Beta2.38
Avg volume67.3K
Discussion

XBIO News

Stories mentioning XBIO from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue807.00766.001,027590.00593.00649.00614.00726.00
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development661.00773.00756.00657.00879.001,042368.00934.00
Sales General & Admin
Total Operating Expenses1,3091,3891,5721,3141,5361,7481,1142,064
Operating Income (Loss)(502.00)(624.00)(545.00)(724.00)(942.00)(1,100)(499.00)(1,337)
Interest Income46.0039.00
Interest Expense
Other Expense0.001.004.001.000.00(8.00)2.000.00
Pretax Income
Tax Provision0.000.000.000.000.000.000.000.00
Net Income (Loss)(456.00)(579.00)(510.00)(689.00)(903.00)(1,054)(437.00)(1,274)
Earnings Per Share (Basic)(0.20)(0.34)(0.33)(0.45)(0.59)(0.68)(0.28)(0.83)
Earnings Per Share (Diluted)(0.20)(0.34)(0.33)(0.45)(0.59)(0.68)(0.28)(0.83)
Weighted Average Shares Outstanding (Basic)2,2911,7021,5421,5421,5421,5411,5421,541
Weighted Average Shares Outstanding (Diluted)2,2911,7021,5421,5421,5421,5411,5421,541

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About XBIO

Xenetic Biosciences, Inc. (NASDAQ: XBIO) is a stock listed on the Nasdaq Stock Market under the ticker symbol XBIO. It last traded at $1.82 (Oct 26, 2026, 2:08 PM ET), up 5.8% on the day. That gives Xenetic Biosciences a market capitalisation of $4.5M.

Over the past 52 weeks XBIO has traded between $1.72 and $4.94.

Revenue for the quarter ended Mar 31, 2026 was $807.0K; a net loss of $456.0K. Revenue was up 36.1% from $593.0K in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$807.0K-$456.0K-56.5%
Dec 31, 2025$766.0K-$579.0K-75.6%
Sep 30, 2025$1.0M-$510.0K-49.7%
Jun 30, 2025$590.0K-$689.0K-116.8%

From Xenetic Biosciences’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…